IECM
ABMD

Intrinsic Edge Capital Management’s Abiomed Inc ABMD Stock Holding History

Intrinsic Edge Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-7,151
Closed -$806K – 169
2016
Q4 		$806K Buy
+7,151
New +$828K 0.34% 86

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Intrinsic Edge Capital Management's ABMD Position: Q1 2017 in Review

Intrinsic Edge Capital Management sold out of Abiomed Inc (ABMD) in Q1 2017, closing a stake of 7,151 shares — an estimated $806K sold.

Intrinsic Edge Capital Management first reported a position in ABMD in Q4 2016 and held it in 1 quarter. The position peaked at $806K in Q4 2016. 287 funds tracked by Wall St. Rank hold ABMD as of Q1 2017.

  • Intrinsic Edge Capital Management reported no remaining Abiomed Inc position as of Q1 2017 after selling out during the quarter.
  • Intrinsic Edge Capital Management sold 7,151 Abiomed Inc shares in Q1 2017, an estimated $806K.
  • Intrinsic Edge Capital Management first reported a position in Abiomed Inc in Q4 2016 and held it in 1 quarter.
  • Intrinsic Edge Capital Management's Abiomed Inc position peaked at $806K in Q4 2016.
  • 287 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2017.

Based on Intrinsic Edge Capital Management's 13F filing for Q1 2017, filed 12 May 2017.